Alliance for Regenerative Medicine CELL & GENE Meeting On The Med 2025

Alliance for Regenerative Medicine CELL & GENE Meeting On The Med 2025

+ Include: 5 videos + 1 pdf, size: 76.68 GB

+ Target Audience: researchers, biotech entrepreneurs

+ Information:

The Cell & Gene Meeting on the Mediterranean (Meeting on the Med) 2025, organized by the Alliance for Regenerative Medicine, is Europe’s foremost conference for advanced therapy stakeholders. This hybrid event brings together leading companies, investors, regulators, and researchers in the cell and gene therapy sector to explore commercialization, manufacturing, regulatory frameworks, and financing of next-generation treatments.

What You Will Learn

• Key challenges and opportunities in bringing cell and gene therapies to market—including regulatory strategies, market access, and clinical development

• Best practices in manufacturing scale-up, quality assurance, and supply chain logistics specific to advanced therapies

• Financial and investment insights tailored to advanced biotechnology companies navigating fundraising and public-private partnerships

• Firsthand lessons from company presentations, industry panels, and thought-leader insights across different stages of the therapy lifecycle

Event Details

• Event: ARM Cell & Gene Meeting on the Mediterranean 2025

• Dates: April 15–17, 2025 (in-person); April 21–22, 2025 (virtual partnering access)

• Location: Rome Cavalieri, Rome, Italy

• Format: Hybrid delivery combining live in-person sessions, one-on-one partnering, interactive workshops, and virtual streaming

• Highlights:

  • Over 50 corporate presentations

  • Extensive partnering opportunities (1000+ one-on-one meetings)

  • Expert-led panels and fireside chats

  • Networking receptions and collaborative industry sessions

Who Should Attend
Executives, researchers, biotech entrepreneurs, investors, regulators, manufacturing experts, and patient advocates engaged in the cell and gene therapy ecosystem—especially those seeking to accelerate commercialization and global adoption of advanced therapies.

Why Attend
This event unites the most relevant commercial, scientific, and regulatory perspectives in one of biotechnology’s fastest-moving fields. Participants gain invaluable connections, practical insight into industry challenges, and a strategic edge in positioning their innovations for global impact—all within an immersive, hybrid learning format.

+ Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Apirl 15 Salone dei Cavalieri, Section 2.mp4
Apirl 15 Salone dei Cavalieri, Section 3&4.mp4
Apirl 16 Salone dei Cavalieri, Section 2.mp4
Apirl 16 Salone dei Cavalieri, Section 3&4.mp4
Apirl 17 Salone dei Cavalieri, Section 3&4.mp4
CGMED-Event-Program-2025-Digital-Final-2.pdf